Loading organizations...
§ Private Profile · Guangzhou, Guangdong, China
Clinical-stage company developing novel cancer therapies.
Lupeng Pharmaceutical has raised $35.0M across 1 funding round.
Lupeng Pharmaceutical has raised $35.0M in total across 1 funding round.
Lupeng Pharmaceutical has raised $35.0M across 1 funding round. Most recently, it raised $35.0M Pre-Series B in November 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 16, 2022 | $35M Series A Plus | Temasek | Fontus Capital, Kaitai Capital, BIN LI, Lilly Asia Ventures, TF Capital | Announced |
Lupeng Pharmaceutical has raised $35.0M in total across 1 funding round.
Lupeng Pharmaceutical's investors include Temasek, Fontus Capital, Kaitai Capital, Bin Li, Lilly Asia Ventures, TF Capital.